Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Achaogen, Minerva

December 12, 2017 11:41 PM UTC

Antibacterial company Achaogen Inc. (NASDAQ:AKAO) said Kenneth Hillan will step down as CEO, effective Jan. 1. He will remain president and president of R&D. Blake Wise, who has served as president and COO, will become CEO.

Neurology company Minerva Neurosciences Inc. (NASDAQ:NERV) said Remy Luthringer will resign as president, while remaining CEO. Rick Russell will become president. Russell was president and CEO of the North American subsidiary of Stallergenes Greer plc (Euronext:STAGR)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article